Results 91 to 100 of about 210,208 (400)

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

MELD score predicts outcomes in patients with advanced heart failure: A longitudinal evaluation

ESC Heart Failure, Volume 12, Issue 2, Page 839-847, April 2025.
Abstract Aims Advanced heart failure (AHF) is characterized by recurrent episodes of haemodynamic instability and frequent hospitalizations, leading to a progressive decline in quality of life and high mortality rates. The objectives of this study were to evaluate the effect of the model for end‐stage liver disease (MELD) score and its variations in ...
Francesco Curcio, Cristiano Amarelli, Rosaria Chiappetti, Irene Mattucci, Veronica Flocco, Mahmoud Issa Rammal, Ciro Abete, Francesca Mazzella, Ciro Maiello, Pasquale Abete, Francesco Cacciatore   +10 more
wiley   +1 more source

Factors associated with cardiovascular events after simultaneous liver–kidney transplant from the US Multicenter Simultaneous Liver–Kidney Transplant Consortium

Hepatology Communications, EarlyView., 2022
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo, Gonzalo Crespo, Dyanna Gregory, Jasmine Sinha, Jiaheng Xie, Min Zhang, John Magee, Pranab Barman, Yuval A. Patel, Aaron Schluger, Kara Walters, Scott Biggins, Natalia Filipek, Giuseppe Cullaro, Randi Wong, Jennifer C. Lai, Gabriel J. Perreault, Elizabeth C. Verna, Pratima Sharma, Lisa B. VanWagner   +19 more
wiley   +1 more source

Mitral valve replacement using a collar-reinforced mitral prosthesis for severe mitral annular calcification, which secures implantation in both the supra-annular and intra-atrial positions: a case report

Journal of Cardiothoracic Surgery, 2023
Background Appropriate management of mitral annular calcification associated with mitral valve surgery must be determined on a case-by-case basis. However, an established procedure remains uncertain.
Atsushi Morishita, Hideyuki Tomioka, Seiichiro Katahira, Takeshi Hoshino, Kazuhiko Hanzawa   +4 more
doaj   +1 more source

On-pump fibrillating heart mitral valve replacement with the SAPIEN™ XT transcatheter heart valve [PDF]

, 2017
In some high-risk patients, standard mitral valve replacement can represent a challenging procedure, requiring a risky extensive decalcification of the annulus. In particular, high-risk redo patients and patients with a previously implanted transcatheter
Ferrari, Enrico, Locca, Didier, Marcucci, Carlo, Niclauss, Lars   +3 more
core  

Robotically assisted mitral valve replacement [PDF]

The Journal of Thoracic and Cardiovascular Surgery, 2012
In the present study, we determined the safety and efficacy of robotic mitral valve replacement using robotic technology.From January 2007 through March 2011, more than 400 patients underwent various types of robotic cardiac surgery in our department. Of these, 22 consecutive patients underwent robotically assisted mitral valve replacement.
Cangsong Xiao, Ming Yang, Yang Wu, Jia-li Wang, Jiachun Li, Changqing Gao, Gang Wang   +6 more
openaire   +3 more sources

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Repeat crossclamp after failed initial degenerative mitral valve repair is safe and successfulCentral MessagePerspective

JTCVS Open, 2023
Objective: Surgical risk and long-term outcomes when re-crossclamp is required during degenerative mitral valve repair are unknown. We examined the outcomes of patients who required re-crossclamp for mitral valve reintervention.
Catherine M. Wagner, MD, Whitney W. Fu, MD, Alexander A. Brescia, MD, MSc, Robert B. Hawkins, MD, MSc, Matthew A. Romano, MD, Gorav Ailawadi, MD, MBA, Steven F. Bolling, MD   +6 more
doaj  

Methods of estimation of mitral valve regurgitation for the cardiac surgeon

Journal of Cardiothoracic Surgery, 2009
Mitral valve regurgitation is a relatively common and important heart valve lesion in clinical practice and adequate assessment is fundamental to decision on management, repair or replacement.
Baikoussis Nikolaos G, Apostolakis Efstratios E   +1 more
doaj   +1 more source

Early results after mitral valvuloplasty for pure mitral regurgitation [PDF]

, 2017
In this study we present the results of 105 consecutive patients with pure mitral regurgitation who underwent surgical treatment. In all patients mitral regurgitation was associated with mitral valve prolapse: 54 patients underwent mitral valvuloplasty ...
EGLOFF, L., GALLINO, A., HIRZEL, H. O., HURNI, R., JENNI, R., KRAYENBÜHL, H. P., ROTHLIN, M., SCHÖNBECK, M., TURINA, M.   +8 more
core